Αρχική World News Quadruplet Isa-KRd Regimen Improves NGS-MRD Negativity in Transplant-Eligible Patients with Newly Diagnosed... World News Quadruplet Isa-KRd Regimen Improves NGS-MRD Negativity in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma Από Ogkologos - 20 Απριλίου, 2026 384 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the EMN24 IsKia study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Navigating the Challenges of Gynecologic Cancer Survivorship: An Expert Perspective 10 Μαΐου, 2022 Personalised blood test could help predict which lung cancers might return 1 Απριλίου, 2022 97-Year-Old Cancer Survivor Credits Her Success With Wanting To Attend A... 28 Οκτωβρίου, 2021 No OS Improvement with CDK4/6 Inhibitors Used in First- Compared with... 3 Μαρτίου, 2026 Φόρτωση περισσοτέρων HOT NEWS Arsenic Trioxide in Combination with All-Trans Retinoic Acid for the Treatment... Neoadjuvant Nivolumab Plus Chemotherapy Results in Significantly Longer Event-Free Survival in... 37-Year-Old Mom Breaks American Marathon Record EMA Recommends Granting a Marketing Authorisation for Ensartinib